semaglutide crohn's Semaglutide-Induced Small Bowel Pseudo-Obstruction and Ileitis in a Patient With Type 2 Diabetes: A Case Report Semaglutide & Crohn's Disease: Safety
Description
Objective To evaluate the efficacy of adjunctive semaglutide on glycemic control, weight-associated outcomes, and cardiometabolic risk factors in individuals with schizophrenia spectrum disorders receiving clozapine or olanzapine and exhibiting early glycemic abnormalities
Targeted Nano-Based Systems for the Anti-Obesity Agents Delivery
Alli has been suffering from extreme night sweats since she was quite young
Tirzepatide starts at 2.5 mg weekly (Mounjaro), increasing by 2.5 mg every 4 weeks until the desired maintenance dose (up to 15 mg ) is reached
JAMA 2022;327:534545 [DOI] [PMC free article] [PubMed] [Google Scholar] 132
